ST
KITE

Spot Trading’s Kite Pharma, Inc. KITE Stock Holding History

Spot Trading’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.35M Buy
7,493
+1,526
+26% +$213K 0.02% 965
2017
Q2 		$619K Sell
5,967
-3,099
-34% -$253K 0.01% 1429
2017
Q1 		$712K Buy
9,066
+8,124
+862% +$502K 0.02% 986
2016
Q4 		$42K Buy
942
+709
+304% +$34.8K ﹤0.01% 2433
2016
Q3 		$13K Sell
233
-1,900
-89% -$106K ﹤0.01% 2869
2016
Q2 		$107K Buy
+2,133
New +$105K ﹤0.01% 2513
2015
Q4 		– Sell
-1,440
Closed -$80K – 4348
2015
Q3 		$80K Buy
+1,440
New +$90.6K ﹤0.01% 3134
2015
Q2 		– Sell
-4,208
Closed -$240K – 4485
2015
Q1 		$243K Buy
+4,208
New +$282K ﹤0.01% 2615

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Spot Trading's KITE Position: Q3 2017 in Review

Spot Trading increased its Kite Pharma, Inc. (KITE) stake by 26% in Q3 2017, buying an estimated $213K and bringing the position to 7,493 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #965.

Spot Trading first reported a position in KITE in Q1 2015 and has held it in 8 quarters since. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Spot Trading held 7,493 shares of Kite Pharma, Inc. worth $1.35M as of Q3 2017.
  • Spot Trading bought 1,526 Kite Pharma, Inc. shares in Q3 2017, an estimated $213K.
  • Kite Pharma, Inc. made up 0.02% of Spot Trading's portfolio in Q3 2017, its #965 holding.
  • Spot Trading first reported a position in Kite Pharma, Inc. in Q1 2015 and has held it in 8 quarters since.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.